The effect of the presence of biosurfactant on the permeation of pharmaceutical compounds through silicone membrane

Lorena Rodriguez-Lopez, Dina Shokry, Jose Cruz, Ana Moldes, Laura Waters

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The permeation of ten model drugs through silicone membrane was analysed to investigate the effect of the presence of a biosurfactant obtained from corn steep liquor. The ten selected pharmaceutical compounds were chosen to include a diverse range of physicochemical properties, such as variable hydrophobicities, pKa’s, molecular masses and degrees of ionisation. When compared with compound permeation alone, the additional inclusion of biosurfactant in the donor phase altered the rate and extent of permeation. It significantly enhanced permeation for five of the compounds, whereas it decreased permeation for four of the compounds and remained approximately the same for the tenth compound. These effects were observed at both biosurfactant concentrations considered, namely 0.005 mg/mL, i.e. below the critical micellar concentration (CMC) and 0.500 mg/mL, i.e. above the CMC of the biosurfactant. Upon analysing permeation change with respect to physicochemical properties of the compounds, it was determined that compounds with a relative molecular mass below 200 resulted in an increase in permeation with biosurfactant present, and those above 200 resulted in a decrease in permeation with biosurfactant present. This effect was therefore attributed to the formation of a drug-biosurfactant interaction that enhanced permeation of smaller compounds, yet retarded permeation for those with a higher molecular mass. These in vitro findings can be considered an indication of potential novel formulation options that incorporate biosurfactant to create transdermal products that have bespoke permeation profiles.
Original languageEnglish
Pages (from-to)456-461
Number of pages6
JournalColloids and Surfaces B: Biointerfaces
Volume176
Early online date18 Jan 2019
DOIs
Publication statusPublished - 1 Apr 2019

Fingerprint

silicones
Silicones
Permeation
Drug products
membranes
Membranes
drugs
Hydrophobic and Hydrophilic Interactions
Drug Interactions
Pharmaceutical Preparations
Zea mays
corn
hydrophobicity
Molecular mass
indication
inclusions
formulations
ionization
products
profiles

Cite this

@article{be92ef633e86428d8dda0759ee19cd5b,
title = "The effect of the presence of biosurfactant on the permeation of pharmaceutical compounds through silicone membrane",
abstract = "The permeation of ten model drugs through silicone membrane was analysed to investigate the effect of the presence of a biosurfactant obtained from corn steep liquor. The ten selected pharmaceutical compounds were chosen to include a diverse range of physicochemical properties, such as variable hydrophobicities, pKa’s, molecular masses and degrees of ionisation. When compared with compound permeation alone, the additional inclusion of biosurfactant in the donor phase altered the rate and extent of permeation. It significantly enhanced permeation for five of the compounds, whereas it decreased permeation for four of the compounds and remained approximately the same for the tenth compound. These effects were observed at both biosurfactant concentrations considered, namely 0.005 mg/mL, i.e. below the critical micellar concentration (CMC) and 0.500 mg/mL, i.e. above the CMC of the biosurfactant. Upon analysing permeation change with respect to physicochemical properties of the compounds, it was determined that compounds with a relative molecular mass below 200 resulted in an increase in permeation with biosurfactant present, and those above 200 resulted in a decrease in permeation with biosurfactant present. This effect was therefore attributed to the formation of a drug-biosurfactant interaction that enhanced permeation of smaller compounds, yet retarded permeation for those with a higher molecular mass. These in vitro findings can be considered an indication of potential novel formulation options that incorporate biosurfactant to create transdermal products that have bespoke permeation profiles.",
keywords = "PDMS, Biosurfactant, Permeation, Membrane, Polydimethylsiloxane, Flow-through diffusion",
author = "Lorena Rodriguez-Lopez and Dina Shokry and Jose Cruz and Ana Moldes and Laura Waters",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.colsurfb.2018.12.072",
language = "English",
volume = "176",
pages = "456--461",
journal = "Colloids and Surfaces B: Biointerfaces",
issn = "0927-7765",
publisher = "Elsevier",

}

The effect of the presence of biosurfactant on the permeation of pharmaceutical compounds through silicone membrane. / Rodriguez-Lopez, Lorena; Shokry, Dina; Cruz, Jose; Moldes, Ana; Waters, Laura.

In: Colloids and Surfaces B: Biointerfaces, Vol. 176, 01.04.2019, p. 456-461.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effect of the presence of biosurfactant on the permeation of pharmaceutical compounds through silicone membrane

AU - Rodriguez-Lopez, Lorena

AU - Shokry, Dina

AU - Cruz, Jose

AU - Moldes, Ana

AU - Waters, Laura

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The permeation of ten model drugs through silicone membrane was analysed to investigate the effect of the presence of a biosurfactant obtained from corn steep liquor. The ten selected pharmaceutical compounds were chosen to include a diverse range of physicochemical properties, such as variable hydrophobicities, pKa’s, molecular masses and degrees of ionisation. When compared with compound permeation alone, the additional inclusion of biosurfactant in the donor phase altered the rate and extent of permeation. It significantly enhanced permeation for five of the compounds, whereas it decreased permeation for four of the compounds and remained approximately the same for the tenth compound. These effects were observed at both biosurfactant concentrations considered, namely 0.005 mg/mL, i.e. below the critical micellar concentration (CMC) and 0.500 mg/mL, i.e. above the CMC of the biosurfactant. Upon analysing permeation change with respect to physicochemical properties of the compounds, it was determined that compounds with a relative molecular mass below 200 resulted in an increase in permeation with biosurfactant present, and those above 200 resulted in a decrease in permeation with biosurfactant present. This effect was therefore attributed to the formation of a drug-biosurfactant interaction that enhanced permeation of smaller compounds, yet retarded permeation for those with a higher molecular mass. These in vitro findings can be considered an indication of potential novel formulation options that incorporate biosurfactant to create transdermal products that have bespoke permeation profiles.

AB - The permeation of ten model drugs through silicone membrane was analysed to investigate the effect of the presence of a biosurfactant obtained from corn steep liquor. The ten selected pharmaceutical compounds were chosen to include a diverse range of physicochemical properties, such as variable hydrophobicities, pKa’s, molecular masses and degrees of ionisation. When compared with compound permeation alone, the additional inclusion of biosurfactant in the donor phase altered the rate and extent of permeation. It significantly enhanced permeation for five of the compounds, whereas it decreased permeation for four of the compounds and remained approximately the same for the tenth compound. These effects were observed at both biosurfactant concentrations considered, namely 0.005 mg/mL, i.e. below the critical micellar concentration (CMC) and 0.500 mg/mL, i.e. above the CMC of the biosurfactant. Upon analysing permeation change with respect to physicochemical properties of the compounds, it was determined that compounds with a relative molecular mass below 200 resulted in an increase in permeation with biosurfactant present, and those above 200 resulted in a decrease in permeation with biosurfactant present. This effect was therefore attributed to the formation of a drug-biosurfactant interaction that enhanced permeation of smaller compounds, yet retarded permeation for those with a higher molecular mass. These in vitro findings can be considered an indication of potential novel formulation options that incorporate biosurfactant to create transdermal products that have bespoke permeation profiles.

KW - PDMS

KW - Biosurfactant

KW - Permeation

KW - Membrane

KW - Polydimethylsiloxane

KW - Flow-through diffusion

UR - http://www.scopus.com/inward/record.url?scp=85060225394&partnerID=8YFLogxK

U2 - 10.1016/j.colsurfb.2018.12.072

DO - 10.1016/j.colsurfb.2018.12.072

M3 - Article

VL - 176

SP - 456

EP - 461

JO - Colloids and Surfaces B: Biointerfaces

JF - Colloids and Surfaces B: Biointerfaces

SN - 0927-7765

ER -